$16.06
-2.12-11.66%
Last update: Nov 5, 5:31 PM
Janux Therapeutics Inc
JANXNASDAQ
Janux Therapeutics (JANX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.48 | $-0.28 | $-0.52 | $-0.64 |
| Actual | $-0.34 | $-0.35 | $-0.39 | $-0.51 |
| Surprise | +29.2% | -25.0% | +25.0% | +20.3% |
| Revenue | ||||
| Estimate | $6.5M | $21.8M | $6.8M | $71430 |
| Actual | $9.3M | $10.3M | $3.7M | $0 |
| Surprise | +42.5% | -52.8% | -44.7% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.56 | $-0.58 | $-0.61 |
| Revenue | |||
| Consensus | $7.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.34 | $-0.48 | 29.2 % |
| Q2 | Aug 6, 2026 | $-0.35 | $-0.28 | -25.0 % |
| Q1 | May 7, 2026 | $-0.39 | $-0.52 | 25.0 % |
| Q4 | Feb 26, 2026 | $-0.51 | $-0.64 | 20.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $9.29M | $6.52M | 42.5 % |
| Q2 | Aug 6, 2026 | $10.27M | $21.77M | -52.8 % |
| Q1 | May 7, 2026 | $3.73M | $6.75M | -44.7 % |
| Q4 | Feb 26, 2026 | $0 | $71.43K | -100.0 % |
